Condition: Anterior Cruciate Ligament Injuries · Post-Traumatic Osteoarthritis of Knee · Bone Marrow Aspirate Concentrate · Sponsor: Hospital for Special Surgery, New York
The goal of this pilot randomized clinical trial is to look into the efficacy of concentrated bone marrow aspirate (cBMA) in improving post traumatic osteoarthritis (PTOA) symptoms in patients undergoing revision anterior cruciate ligament reconstruction surgery. The main questions it aims to answer are whether clinical outcomes, such as pain, are improved in patients who get cBMA with surgery, if there is a change in circulating markers of inflammation and what part of the cellular and molecular composition of cBMA may explain its effects.
This description comes directly from the study's public registry record.
Daniel de la Huerta, MD · 917-260-3159 · delahuertamezad@hss.edu
Always discuss trial participation with your own doctor first.
| Emory Orthopaedics & Spine Center | Atlanta, Georgia, United States | Recruiting |
| Hospital for Special Surgery | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06311513